Engineered human FcγRIIa fusion: A novel strategy to extend serum half‐life of therapeutic proteins
Year: 2020
Type: article
Source: Biotechnology and Bioengineering
DOI: 10.1002/bit.27374
Institutions: Kookmin University, Korea University, Eulji University
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3022251295
